U.S. federal trademark · Serial No. 86030250 · Reg. No. 4608315
Research and development in the field of cancer therapeutics, cardiovascular therapeutics, oncology, cardiovascular disease, nanoparticles, and targeted therapies; Pharmaceutical services, namely, developing tumor and cardiovascular targeting platform technologies
Providing therapeutic treatments and diagnostic imaging agents for cancer and vascular disease
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.